28 Jul 2026Open access
Metal–organic framework-based therapeutic strategies for hepatocellular carcinoma: current advances and future perspectivesPublisher siteCancer Nanotechnology, Nanoplatforms for cancer theranostics
UniversitiesSherif Ashraf Fahmy
Active, last published 2026
In nanoparticle-based drug delivery
Sherif Ashraf
Fahmy
Scholar“Research focused on Nanoparticle-Based Drug Delivery and adjacent fields.”
Philipps University of Marburg
Claim Your Profile30
H-index
2.3k
Citations
Sherif has not officially claimed their profile. If you are Sherif, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
herif Ashraf Fahmy is a researcher working on Nanoparticle-Based Drug Delivery. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Sherif's work has been cited 2,286 times across 4 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Nanoparticle-Based Drug Delivery×17Nanoplatforms for cancer theranostics×12RNA Interference and Gene Delivery×9MicroRNA in disease regulation×8Nanoparticles: synthesis and applications×8
04 · Where I am
Affiliations
Affiliation on published researchPhilipps University of MarburgDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
30 works19 Jun 2026Open access
Artificial intelligence-driven methods and nanoparticle-based biosensors for rapid and sensitive detection of EGFR mutations in non-small cell lung cancerPublisher siteCancer Nanotechnology, Lung Cancer Treatments and Mutations
1 Jun 2026
Triazole–Sulfonamide Hybrids as Carbonic Anhydrase Inhibitors: Emerging Chemistry and Bioactivity Insights From 2020 to 2025Publisher siteArchiv der Pharmazie, Enzyme function and inhibition
1 May 2026Open access
Dual‐Function Lipid‐Based Nanovector Strategy for Glioblastoma Immunotherapy: STING Activation and M1 Microglia PolarizationPublisher siteDrug Development Research, interferon and immune responses
21 Apr 2026Open access
Correction: Fahmy et al. PEGylated Chitosan Nanoparticles Encapsulating Ascorbic Acid and Oxaliplatin Exhibit Dramatic Apoptotic Effects against Breast Cancer Cells. Pharmaceutics 2022, 14, 407Publisher sitePharmaceutics, Curcumin's Biomedical Applications
17 Apr 2026Open access
Correction: Fahmy et al. Palladium Nanoparticles Fabricated by Green Chemistry: Promising Chemotherapeutic, Antioxidant and Antimicrobial Agents. Materials 2020, 13, 3661Publisher siteMaterials, Nanoplatforms for cancer theranostics
4 Apr 2026Open access
Reprogramming cancer therapeutics through artificial intelligence-guided drug repurposing: Computational innovation, experimental validation, and translational challengesPublisher siteArtificial Intelligence in the Life Sciences, Pluripotent Stem Cells Research
1 Dec 2025Open access4cites
Next‐Generation Proteolysis‐Targeting Chimeras in Precision Oncology: Multifunctional Designs, Emerging Modalities, and Translational Prospects in Targeted Protein DegradationPublisher siteDrug Development Research, Protein Degradation and Inhibitors
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Sherif?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you